Leprosy Mailing List – December 24, 2017
Ref.: (LML) Chemoprophylaxis in Leprosy
From: Diana Lockwood, London, UK
I and several other academics working in leprosy have concerns about the recommendation that single dose Rifampicin should be used as chemo-prophylaxis. These concerns relate to efficacy, the ethics of household contact tracing, likely problems with compliance and the risk of promoting Rifampicin resistance in M. leprae.
We have written to Erwin Cooreman, Head of the Global Leprosy Programme and Anil Kumar the Head of the Indian Leprosy programme. We here share the letter with the Leprosy Mailing List.
We are hoping for a useful discussion.
Professor of Tropical Medicine
London School of Hygiene & Tropical Medicine
London WC1E 7HT
Tel: 020 7927 2457
visit my blog http://dnjtravels.blogspot.co.uk/
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << email@example.com